Overview
Module 2 of the Joint DIA/MEB "Excellence in Pharmacovigilance" virtual live training course will provide the safety reporting requirements with case studies, the roles, and responsibilities of all stakeholders in clinical trials in line with the implementing texts published in relation to Directive 2001/20/EC and the new Regulation (EU) 536/2014.
This module will also provide an understanding of safety data classification, using MedDRA terminology and safety data retrieval using Standardised MedDRA Queries (SMQs).
- "Excellence in Pharmacovigilance" Module 1: Post-Marketing
- "Excellence in Pharmacovigilance" Module 2: Safety Aspects in Clinical Trials
- "Excellence in Pharmacovigilance" Module 3: Quality Management System
- "Excellence in Pharmacovigilance" Module 4: Risk Management
- "Excellence in Pharmacovigilance" Module 5: Signal Management
Program Committee
-
Wendy Huisman, PharmD Director
Vigifit, Netherlands -
Fakhredin Sayed Tabatabaei, MD, PhD Senior Assessor
MEB, Netherlands
Have an account?